Creapharma.com is listing here some interesting companies in AI in biotech and pharma world. We will update on a regular basis.
USA
California
Iambic Therapeutics
Iambic’s cutting-edge AI-driven platform tackles the most challenging design problems in drug discovery, addressing unmet patient need.
Field: design of small molecules
Location: San Diego (CA)
Website: www.iambic.ai
Terray Therapeutics
Terray exists to change the way experimentation and computation work together. Terray Therapeutics believes high-quality data at scale is the key to unlocking generative AI for small molecules.
Field: design of small molecules
Location: Monrovia (CA)
Website: www.terraytx.com
Genesis Therapeutics
Genesis uses the industry’s most advanced molecular AI platform to unlock tough protein targets and invent medicines with unprecedented potency and selectivity.
Field: design of small molecules (proteins)
Locations: Burlingame (CA), San Diego (CA)
Website: genesistherapeutics.ai
Utah
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering (source: Wikipedia in English).
Note: In August 2024, the company acquired UK-based biotechnology company Exscientia for $688 million.
Location: Salt Lake City (Utah)
Founded: 2013
Website: www.recursion.com
Leash
Leash is transforming drug design with a rich dataset built by screening millions of compounds against thousands of proteins to generate billions of data points, ideal for training advanced machine learning models.
Field: design of small molecules
Location: Salt Lake City (Utah)
Website: www.leash.bio
Canada
ViewsML
A technology that virtualizes IHC (Immunohistochemistry) using AI deep learning to predict biomarker expression, both spatially and quantitatively, at the cellular level.
Location: Vancouver (BC)
Website: www.viewsml.com
Europe
UK
BenevolentAI
A leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases.
Location: London
Website: www.benevolent.com
Isomorphic Lab (owned by Google, Alphabet Inc.)
Isomorphic Labs apples AI and computational methods to drug discovery, and transform the way medicine helps and heals people.
Field: design of small molecules
Locations: London (UK), Lausanne (CH)
Founded: 2021
Website: www.isomorphiclabs.com
Deepmind (owned by Google, Alphabet Inc.)
DeepMind Technologies Limited is an artificial intelligence research laboratory which serves as a subsidiary of Google. In 2020, DeepMind made significant advances in the problem of protein folding with AlphaFold (in 2024 it was AlphaFold 3).
Location: London
Website: deepmind.google
Germany
StratifAI
StratifAI develops multimodal artificial intelligence models that deliver meaningful prognostic insights from routinely available histology images and clinical data to guide treatment decisions in oncology.
Location: Dresden
Founded: 2018/2023 (company founded)
Website: stratifai.com
Switzerland
Protocol AI
Protocol AI TM software is an end-to-end solution that enables experts to design and develop high-quality protocols and study plans rapidly and efficiently, helping companies shorten clinical development timelines and accelerate the delivery of new treatments to market.
Location: Bern (BE)
Website: viewsml.com
Asie
Hong Kong
Insilico Medicine
Insilico Medicine is a biotechnology company based in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery.
Locations: Hong Kong, (New York and Boston, USA)
Website: insilico.com
Last update: December 03, 2024. By Xavier Gruffat (pharmacist from ETH Zurich, Switzerland, MBA). Sources: The Economist, many sources via Google.
